The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Rationale and design of the Optimal Macro-Nutrient Intake Heart Trial to Prevent Heart Disease (OMNI-Heart).
Vincent J Carey; Louise Bishop; Jeanne Charleston; Paul Conlin; Tate Erlinger; Nancy Laranjo; Phyllis McCarron; Edgar Miller; Bernard Rosner; Janis Swain; et al. (Profiled Authors: Lawrence Appel; Edgar Miller; Jeanne Charleston)
Channing Laboratory, Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. email@example.com
Clinical trials (London, England) 2005;2(6):529-37.
BACKGROUND: The DASH (Dietary Approaches to Stop Hypertension) diet is a carbohydrate-rich, reduced-fat diet that lowers blood pressure (BP) and LDL-cholesterol. Whether partial replacement of some carbohydrate (C) with either protein (P) or unsaturated fat (U) can further improve these and other cardiovascular (CVD) risk factors is unknown. METHODS: OmniHeart is a randomized, three-period, crossover feeding study designed to compare the effects on BP and blood lipids of a carbohydrate-rich diet (CARB, similar to the DASH diet) with a diet rich in protein (PROT, predominantly from nonmeat sources) and a diet rich in unsaturated fat (UNSAT, predominantly monounsaturated). Throughout feeding (run in and the three intervention periods), participants are provided with all of their meals that meet the nutrient profile of their assigned diet. Calorie intake is adjusted to maintain weight. The target sample size is 160 (50% African-American). Participants are adults, aged 30 or older, with prehypertension or Stage 1 hypertension (systolic BP 120-159 or diastolic BP 80-99 mmHg). The primary outcome variables are systolic BP and LDL-cholesterol. Secondary outcomes are diastolic BP, HDL-cholesterol, and triglycerides. Other outcome variables are total cholesterol, apolipoproteins VLDL-apoB, VLDL-apoCIII, apolipoprotein B, non-HDL cholesterol, and lipoprotein(a), and insulin resistance, as measured by Homeostasis Model Assessment (HOMA). CONCLUSIONS: OMNI-Heart should advance our fundamental knowledge of the effects of diet on both traditional and emerging risk factors, and, in the process, guide policy makers, health care providers and the general public on the relative benefits of carbohydrate, protein, and unsaturated fat as a means to reduce CVD risk.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Janis F Swain; Phyllis B McCarron; Eileen F Hamilton; Frank M Sacks; Lawrence J AppelJournal of the American Dietetic Association 2008;108(2):257-65.
Jeannette M Beasley; Brett A Ange; Cheryl A M Anderson; Edgar R Miller; Thomas P Erlinger; Janet T Holbrook; Frank M Sacks; Lawrence J AppelAmerican journal of epidemiology 2009;169(7):893-900.
Jeremy D Furtado; Hannia Campos; Lawrence J Appel; Edgar R Miller; Nancy Laranjo; Vincent J Carey; Frank M SacksThe American journal of clinical nutrition 2008;87(6):1623-30.
Appears in this Publication
Author of this Publication